The Federal Drug Administration has released an updated list of North Texas healthcare facilities that received recalled products from a New England pharmaceutical distributorship at the center of a nationwide meningitis outbreak, according to a report from WFAA:
Not every facility on the list received contaminated products, but all of them were sent some type of recalled medicine from the compounding pharmacy, including three facilities that treat children:
• Children’s Medical Center Dallas
• Children’s Medical Center at Legacy
• Cosmetic & Maxillofacial Surgery Center Dallas
• Dallas Back Pain Management
• Dallas Plastic Surgery
• Dr. Douglas Lorimer, Fort Worth
• Mansfield Surgery Center
• Our Children’s House at Baylor Dallas
Two previously medical facilities on the FDA list include:
• Texas Health Southlake
• Medical City Dallas Hospital
The agency urged clinics on its list to double-check their stocks and stop using any products the pharmaceutical concern in question.